Anti-inflammatory actions of glucocorticoids: Molecular mechanisms

Clinical Science

Volumn 94, Issue 6, 1998, Pages 557-572

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Asthma; Glucocorticoid; Inflammation; Transcription factor

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CELL ADHESION MOLECULE; CYCLOSPORIN; CYTOKINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; LIPOCORTIN 1; MEMBRANE METALLOENDOPEPTIDASE; RETINOIC ACID; TACROLIMUS; TRANSCRIPTION FACTOR;

ACETYLATION; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ASTHMA; CELL SURVIVAL; CHROMATIN STRUCTURE; CYTOKINE RELEASE; DEACETYLATION; DENDRITIC CELL; DNA DENATURATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG RESISTANCE; DRUG TARGETING; DRUG USE; ENTERITIS; EOSINOPHIL; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; MACROPHAGE; MAST CELL; MUCUS SECRETION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; REVIEW; T LYMPHOCYTE; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0031862891     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0940557     Document Type: Review

References (178)

1. Barnes PJ. Inhaled glucocorticoids for asthma. (1995) N Engl J Med 332: 868-75.
2. Barnes PJ. (1996) Molecular mechanisms of steroid action in asthma. J Allergy Clin Immunol 97: 159-68.
3. Barnes PJ. (1996) Mechanism of action of glucocorticoids in asthma. Am J Respir Crit Care Med 154: S21-7.
4. Bamberger CM, Bamberger AM, de Castr M, Chrousos GP. (1995) Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95: 2435-41.
5. Muller M, Renkawitz R. (1991) The glucocorticoid receptor. Biochim Biophys Acta 1088: 171-82.
6. Gronemeyer H. (1992) Control of transcription activation by steroid hormone receptors. FASEB J 6: 2524-9.
7. Beato M, Herrlich P, Schutz G. (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83: 851-7.
8. Lieberman BA, Nordeen SK. (1997) DNA intersegment transfer, how steroid receptors search for a target site. J Biol Chem 272: 1061-8.
9. Drouin J, Sun YL, Chamberland M, et al. (1993) Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J 12: 145-56.
10. Meyer T, Gustafsson JA, Carlstedt Duke J. (1997) Glucocorticoid-dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box. DNA Cell Biol 16: 919-27.
11. Luisi BF, Xu WX, Otwineski Z, Fredman LP, Yamamoto KR, Sigler PS. (1991) Cristallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature (London) 352: 497-505.
12. Miner JN, Yamamoto KR. (1991) Regulatory crosstalk at composite response elements. Trends Biochem Sci 16: 423-6.
13. Bickel M, Iwai Y, Pluznik DH, Cohen RB. (1992) Binding of sequence-specific proteins to the adenosine-plus uridine-rich sequences of the murine granulocyte/macrophage colony-stimulating factor mRNA. Proc Natl Acad Sci USA 89: 10001-5.
14. Ristimaki A, Narko K, Hla T. (1996) Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J 318: 325-31.
15. Truss M, Beato M. (1993) Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrine Rev 14: 459-79.
16. Pfahl M. (1993) Nuclear receptor/AP-1 interaction. Endocrine Rev 14: 651-8.
17. Barnes PJ, Adcock IM. (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 14: 436-41.
18. Adcock IM, Shirasaki H, Gelder CM, Peters MJ, Brown CR, Barnes PJ (1994). The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung. Life Sci 55: 1147-53.
19. Adcock IM, Brown CR, Gelder CM, Shirasaki H, Peters MJ, Barnes PJ. (1995) The effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am J Physiol 37: C331-8.
20. Barnes PJ, Karin M. (1997) Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-71.
21. Ray A, Prefontaine KE. (1994) Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci USA 91: 752-6.
22. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS. (1996) Characterization of the mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol 15: 943-53.
23. Caldenhoven, Liden J, Wissink S, et al. (1995) Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9: 401-12.
24. Imai F, Minger JN, Mitchell JA, Yamamoto KR, Granner DK. (1993) Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 268: 5353-6.
25. Peters MJ, Adcock IM, Brown CR, Barnes PJ. (1995) β-Adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharmacol (Mol Pharmacol Section) 289: 275-81.
26. Nordeen SK, Bona BJ, Beck CA, Edwards DP, Borror KC, DeFranco DB. (1995) The two faces of a steroid antagonist: when an antagonist isn't. Steroids 60: 97-104.
27. Moriggl R, Berchtold S, Friedrich K, et al. (1997) Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells. Mol Cell Biol 17: 3663-78.
28. Adcock IM, Barnes PJ. (1996) Tumour necrosis factor alpha causes retention of activated glucocorticoid receptor within the cytoplasm of A549 cells. Biochem Biophys Res Commun 225: 1127-32.
29. Janknecht R, Hunter T. (1996) A growing coactivator network. Nature (London) 383: 22-3.
30. Arias J, Alberts AS, Brindle P, et al. (1994) Activation of cAMP and mitogen responsive genes relies on a common nuclear factor [see comments]. Nature (London) 370: 226-9.
31. Kamei Y, Xu L, Heinzel T, et al. (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-14.
32. Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Darnell JE. (1996) Two contact regions between STAT1 and CBP/p300 in interferon-γ signalling. Proc Natl Acad Sci USA 93: 15092-6.
33. Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ. (1997) Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science (Washington DC) 275: 523-6.
34. Smith CL, Onate SA, Tsai MJ, O'Malley BW. (1996) CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci USA 93: 8884-8.
35. Yao PM, Buhler JM, D'Ortho MP, et al. (1996) Expression of matrix metalloproteinase gelatinases A and B by cultured epithelial cells from human bronchial explants. J Biol Chem 271: 15580-9.
36. Hong H, Kohli K, Garabedian MJ, Stallcup MR. (1997) GRIPI, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17: 2735-44.
37. Torchia J, Rose DW, Inostroza J, et al. (1997) The trancriptional coactivator p/CIP binds CBP and mediates nuclear receptor function. Nature (London) 387: 677-84.
38. Heery DM, Kalkhoven E, Hoare S, Parker MG. (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature (London) 387: 733-6.
39. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-9.
40. Wolffe AP. (1997) Sinful repression. Nature (London) 387: 16-17.
41. Nagy L, Kao HY, Chakravarti D, et al. (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89: 373-80.
42. Heinzel T, Lavinsky RM, Mullen TM, et al. (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature (London) 387: 43-8.
43. Flower RJ, Rothwell NJ. (1994) Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 15: 71-6.
44. Dennis EA. (1994) Diversity of group types, regulation and function of phospholipase A2. J Biol Chem 269: 13057-60.
45. Abbinante-Nissen JM, Simpson LG, Leikauf GD. (1995) Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol 12: L601-6.
46. Zhang Z, Zimonjic DB, Popescu NC, et al. (1997) Human uteroglobin gene: structure, subchromosomal localization, and polymorphism. DNA Cell Biol 16: 73-83.
47. Levine SJ, Benfield T, Shelhamer JH. (1996) Corticosteroids induce intracellular interleukin-1 receptor antagonist type 1 expression by a human airway epithelial cell line. Am J Respir Cell Mol Biol 15: 245-51.
48. Sousa AR, Lane SJ, Nakhosteen JA, Lee TH, Poscon RN. (1996) Expression of interleukin-1 beta (IL-1β) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. Am J Respir Crit Care Med 154: 1061-6.
49. Colotta F, Re F, Muzio M, et al. (1993) Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science (Washington DC) 261: 472-5.
50. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. (1995) Interleukin (IL)-10 inhibits nuclear factor κB activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 270: 9558-63.
51. John M, Lim S, Seybold J, et al. (1998) Inhaled corticosteroids increase IL-10 but reduce MIP-1α, GM-CSF and IFN-γ release from alveolar macrophages in asthma. Am J Respir Crit Care Med 157: 256-62
52. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. (1995) Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science (Washington DC) 270: 286-90.
53. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS. (1995) Role of transcriptional activation of IκBα in mediating immunosuppression by glucocorticoids. Science (Washington DC) 270: 283-6.
54. Brostjan C, Anrather J, Csizmadia V, et al. (1996) Glucocorticoid-mediated repression of NFκB activity in endothelial cells does not involve induction of IκBα synthesis. J Biol Chem 271: 19612-16.
55. Newton R, Hart LA, Adcock IM, Barnes PJ. (1997) Effect of glucocorticoids on IL-1β-induced NF-κB binding and expression in type II alveolar cells - no evidence for downregulation by IκB. Am J Respir Crit Care Med 155: A699
56. Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, Cato AC. (1997) IκBα-independent downregulation of NF-κB activity by glucocorticoid receptor. EMBO J 16: 4698-707.
57. Borson DB, Jew S, Gruenert DC. (1991) Glucocorticoids induce neutral endopeptidase in transformed human trachea epithelial cells. Am J Physiol 260: L83-9.
58. Sont JK, van Krieken JH, van Klink HC, et al. (1997) Enhanced expression of neutral endopeptidase (NEP) in airway epithelium in biopsies from steroid-versus nonsteroid-treated patients with atopic asthma. Am J Respir Cell Mol Biol 16: 549-56.
59. Collins S, Caron MG, Lefkowitz RJ. (1988) β-Adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 263: 9067-70.
60. 2-adrenergic receptor transcription in human lung. Am J Physiol 12: L41-6.
61. 2-adrenergic receptors in vivo. J Clin Invest 96: 99-106.
62. Yates DH, Kharitonov SA, Barnes PJ. (1996) An inhaled glucocorticoid does not prevent tolerance to salmeterol in mild asthma. Am J Respir Crit Care Med 154: 1603-7.
63. Northrop JP, Ullman KS, Crabtree GR. (1993) Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT). J Biol Chem 268: 2917-23.
64. Paliogianni F, Raptis A, Ahuja SS, Najjar SM, Boumpas DT. (1993) Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. J Clin Invest 91: 1481-9.
65. Mori A, Kaminuma O, Suko M, et al. (1997) Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids. Blood 89: 2891-900.
66. Nelson PJ, Kim HT, Manning WC, Goralski TJ, Krensky AM. (1993) Genomic organisation and transcriptional regulation of the RANTES chemokine gene. J Immunol 151: 2601-12.
67. Linden M, Brattsand R. (1994) Effects of a corticosteroid, budesonide, on alveolar macrophages and blood monocyte secretion of cytokines: differential sensitivity of GM-CSF, IL-1β and IL-6. Pulmonary Pharmacol 7: 43-7.
68. Barnes PJ, Liew FY. (1995) Nitric oxide and asthmatic inflammation. Immunol Today 16: 128-30.
69. Barnes PJ. (1995) Nitric oxide and airway disease. Ann Med 27: 389-93.
70. Di Rosa M, Radomski M, Carnuccio R, Moncada S. (1990) Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun 172: 1246-52.
71. Robbins RA, Barnes PJ, Springall DR, et al. (1994) Expression of inducible nitric oxide synthase in human bronchial epithelial cells. Biochem Biophys Res Commun 203: 209-18.
72. Xie Q, Kashiwarbara Y, Nathan C. (1994) Role of transcription factor NF-kB/Rel in induction of nitric oxide synthase. J Biol Chem 269: 4705-8.
73. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne E, Barnes PJ. (1994) Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343: 133-5.
74. Kharitonov SA, Yates DH, Barnes PJ. (1996) Regular inhaled budesonide decreases nitric oxide concentration in the exhaled air of asthmatic patients. Am J Respir Crit Care Med 153: 454-7.
75. Mitchell JA, Belvisi MG, Akarasereemom P, et al. (1994) Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol 113: 1008-14.
76. Yamamoto K, Arakawa T, Ueda N, Yamamoto S. (1995) Transcriptional roles of nuclear factor kB and nuclear factor-interleukin 6 in the tumor necrosis-α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 270: 31315-20.
77. 2 and COX-2 mRNA by proinflammatory cytokines is suppressed by dexamethasone in human airway epithelial cells. Life Sci 60: 67-78.
78. Dworski R, Fitzgerald GA, Oates JA, Sheller JR. (1994) Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 149: 953-9.
79. Andersson SE, Zackrisson C, Hemsen S, Lundberg JA. (1992) Regulation of lung endothelin content by the glucocorticosteroid budesonide. Biochem Biophys Res Commun 188: 1116-21.
80. Vittori E, Marini M, Fasoli A, de Franchis R, Mattoli S. (1992) Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids. Am Rev Respir Dis 146: 1320-5.
81. Adcock IM, Peters M, Gelder C, Shirasaki H, Brown CR, Barnes PJ. (1993) Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. J Mol Endocrinol 11: 1-7.
82. Ihara H, Nakanishi S. (1990) Selective inhibition of expression of the substance P receptor mRNA in pancreatic acinar AR42J cells by glucocorticoids. J Biol Chem 36: 22441-5.
83. 2-receptor expression in bovine tracheal smooth muscle. Eur J Pharmacol (In press).
84. Owens GP, Hahn WE, Cohen JJ. (1991) Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol Cell Biol 11: 4177-88.
85. Cox G. (1995) Glucocorticoid treatment inhibits apoptosis in human neutrophils. J Immunol 193: 4719-25.
86. Meagher LC, Cousin JM, Seckl JR, Haslett C. (1996) Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 156: 4422-8.
87. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. (1992) A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 89: 9991-5.
88. Van De Stolpe A, Caldenhoven E, Raaijmakers JAM, van der Saag PT, Koendorman L. (1993) Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am J Respir Cell Mol Biol 8: 340-7.
89. 4 by human alveolar and peritoneal macrophages in culture. Clin Sci 67: 693-6.
90. Bergstrand H, Björnson A, Blaschke E, et al. (1990) Effects of an inhaled corticosteroid, budesonide, on alveolar macrophage function in smokers. Thorax 45: 362-8.
91. Martinet N, Vaillant P, Charles T, Lambert J, Martinet Y. (1992) Dexamethasone modulation of tumour necrosis factor-α (cachectin) release by activated normal human alveolar macrophages. Eur Respir J 5: 67-72.
92. 2 and dexamethasone. Am J Respir Cell Mol Biol 4: 75-81.
93. Borish L, Mascali JJ, Dishuck J, Beam WR, Martin RJ, Rosenwasser LJ. (1992) Detection of alveolar macrophage-derived IL-1β in asthma. Inhibition with corticosteroids. J Immunol 149: 3078-82.
94. Kita H, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. (1991) Effect of steroids on immunoglobulin-induced eosinophil degranulation. J Allergy Clin Immunol 87: 70-7.
95. Evans PM, Barnes PJ, Chung KF. (1990) Effect of corticosteroids on human eosinophils in vitro. Eur J Pharmacol 3: 160S
96. Lamas AM, Leon OG, Schleimer RP. (1991) Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J Immunol 147: 254-9.
97. Wallen N, Kita H, Weiller D, Gleich GJ. (1991) Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 147: 3490-5.
98. Owen WF, Rothenberg ME, Silberstein DS, et al. (1987) Regulation of human eosinophil viability, density and function by granulocyte/macrophage colony stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 166: 129-41.
99. Wempe JB, Tammeling EP, Köeter GH, Haransson L, Venge P, Postma DS. (1992) Blood eosinophil numbers and activity during 24 hours; effects of treatment with budesonide and bambuterol. J Allergy Clin Immunol 90: 757-65.
100. Evans PM, O'Connor BJ, Fuller RW, Barnes PJ, Chung KF. (1993) Effect of inhaled corticosteroids on peripheral eosinophil counts and density profiles in asthma. J Allergy Clin Immunol 91: 643-9.
101. Cohan VL, Undem BJ, Fox CC, Adkinson NF, Lichtenstein LM, Schleimer RP. (1989) Dexamethasone does not inhibit the release of mediators from human lung mast cells residing in airway, intestine or skin. Am Rev Respir Dis 140: 951-4.
102. 2 agonist, terbutaline, on airway inflammation in newly diagnosed asthma. J Allergy Clin Immunol 90: 32-42.
103. Holt PG. (1993) Regulation of antigen-presenting cell function(s) in lung and airway tissues. Eur Respir J 6: 120-9.
104. Nelson DJ, McWilliam AS, Haining S, Holt PG. (1995) Modulation of airway intraepithelial dendritic cells following exposure to steroids. Am J Respir Crit Care Med 151: 475-81.
105. Holm AF, Fokkens WJ, Godthelp T, Mulder PG, Vroom TM, Rinjntjes E. (1995) Effect of 3 months' nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis. Allergy 50: 204-9.
106. Adcock IM, Gilbey T, Gelder CM, Chung KF, Barnes PJ. (1996) Glucocorticoid receptor localization in normal human lung and asthmatic lung. Am J Respir Crit Care Med 154: 771-82.
107. Boschetto P, Rogers DF, Fabbri LM, Barnes PJ. (1991) Corticosteroid inhibition of airway microvascular leakage. Ann Rev Respir Dis 143: 605-9.
108. Erjefält I, Persson CGA. (1991) Pharmacologic control of plasma exudation into tracheobronchial airways. Am Rev Respir Dis 143: 1008-14.
109. Carnuccio R, Di Rosa M, Guerrasio B, Luvone T, Satebin L. (1987) Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein. Br J Pharmacol 90: 443-5.
110. van de Graaf EA, Out TA, Loos CM, Jansen HM. (1991) Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Am Rev Respir Dis 143: 362-8.
111. Devalia JL, Wang JH, Sapsford RJ, Davies RJ. (1994) Expression of RANTES in human bronchial epithelial cells and the effect of beclomethasone diproprionate (BDP). Eur Respir J 7 (Suppl 18): 98S.
112. Levine SJ. (1995) Bronchial epithelial cell-cytokine interactions in airway epithelium. J Invest Med 43: 241-9.
113. Schweibert LM, Stellato C, Schleimer RP. (1996) The epithelium as a target for glucocorticoid action in the treatment of asthma. Am J Respir Crit Care Med 154: S16-20.
114. Kwon OJ, Au BT, Collins PD, et al. (1994) Inhibition of interleukin-8 expression in human cultured airway epithelial cells. Immunology 81: 389-94.
115. Kwon OJ, Au BT, Collins PD, et al. (1994) Tumor necrosis factor-induced interleukin 8 expression in cultured human epithelial cells. Am J Physiol 11: L398-405.
116. Kwon OJ, Jose PJ, Robbins RA, Schall TJ, Williams TJ, Barnes PJ. (1995) Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol 12: 488-96.
117. Wang JH, Devalia JL, Xia C, Sapsford RJ, Davies RJ. (1996) Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol 14: 27-35.
118. Sousa AR, Poston RN, Lane SJ, Narhosteen JA, Lee TH. (1993) Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am Rev Respir Dis 147: 1557-61.
119. Trigg CJ, Manolistas ND, Wang J, et al. (1994) Placebo-controlled immunopathological study of four months inhaled corticosteroids in asthma. Am J Respir Crit Care Med 150: 17-22.
120. Shimura S, Sasaki T, Ikeda K, Yamauchi K, Sasaki H, Takishima T. (1990) Direct inhibitory action of glucocorticoid on glycoconjugate secretion from airway submucosal glands. Am Rev Respir Dis 141: 1044-99.
121. Kai H, Yoshitake K, Hisatsune A, et al. (1996) Dexamethasone suppresses mucus production and MUC-2 and MUC-5AC gene expression by NCI-H292 cells. Am J Physiol 271: L484-8.
122. Ding M, Hart RP, Jonakait GM. (1995) Tumor necrosis factor-alpha induces substance P in sympathetic ganglia through sequential induction of interleukin-1 and leukemia inhibitory factor. J Neurobiol 28: 445-54.
123. Barnes PJ, Adcock IM. (1995) Steroid-resistant asthma. Q J Med 88: 455-68.
124. Barnes PJ, Greening AP, Crompton GK. (1995) Glucocorticoid resistance in asthma. Am J Respir Crit Care Med 152: 125-40S.
125. Szefler SJ, Leung DY. (1997) Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management. Eur Respir J 10: 1640-7.
126. Kirkham B, Corkill MM, Davison SC, Panayi GS. (1991) Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assays predicts in vivo response. J Rheumatol 18: 1130-3.
127. Schwartz, Lowell FC, Melby JC. (1968) Steroid resistance in bronchial asthma. Am J Int Med 69: 493-9.
128. Carmichael J, Paterson IC, Diaz P, Crompton GK, Kay AB, Grant IWB. (1981) Corticosteroid resistance in chronic asthma. Br Med J 282: 1419-22.
129. Lane SJ, Atkinson BA, Swimanathan R, Lee TH. (1996) Hypothalamic-pituitary axis in corticosteroid-resistant asthma. Am J Respir Crit Care Med 153: 1510-14.
130. Leung DYM, Martin RJ, Szefler SJ, et al. (1995) Dysregulation of interleukin 4, interleukin 5, and interferon γ gene expression in steroid-resistant asthma. J Exp Med 181: 33-40.
131. Stratakis CA, Karl M, Schulte HM, Chrousos GP. (1994) Glucocorticosteroid resistance in humans. Elucidation of the molecular mechanisms and implications for pathophysiology. Ann NY Acad Sci 746: 362-74.
132. Malchoff DM, Brufsky A, McDermott P, et al. (1993) A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest 91: 1918-25.
133. Moalli PA, Pillay S, Weiner D, Leikin R, Rosen T. (1992) A mechanism of resistance to corticosteroids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA. Blood 79: 213-22.
134. Lane SJ, Arm JP, Staynov DZ, Lee TH. (1994) Chemical mutational analysis of the human glucocortiocoid receptor cDNA in glucocorticoid-resistant bronchial asthma. Am J Respir Cell Mol Biol 11: 42-8.
135. Corrigan C, Brown PH, Barnes NC, et al. (1991) Glucocorticoid resistance in chronic asthma. Am Rev Respir Dis 144: 1016-25.
136. Alvarez J, Surs W, Leung DY, Ikle D, Gelfand EW, Szefler SJ. (1992) Steroid-resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol 89: 714-21.
137. Szefler S. (1991) Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol 88: 147-65.
138. Goulding NJ, Podgorski MR, Hall ND, et al. (1989) Autoantibodies to recombinant liportin-1 in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 48: 843-50.
139. Wilkinson JR, Podgorski MR, Godolphin JL, Goulding NJ, Lee TH. (1990) Bronchial asthma is not associated with auto-antibodies to lipocortin-1. Clin Exp Allergy 20: 189-92.
140. Chung KF, Podgorski MR, Goulding NJ, et al. (1991) Circulating autoantibodies to recombinant lipocortin-1 in asthma. Respir Med 95: 121-4.
141. Wilkinson JRW, Lane SJ, Lee TH. (1991) The effects of corticosteroids on cytokine generation and expression of activation antigens by monocytes in bronchial asthma. Int Arch Allergy Clin Immunol 94: 220-1.
142. Poznansky MC, Gordon ACH, Douglas JG, Krajewski AS, Wyllie AH, Grant IWB. (1984) Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients. Clin Sci 67: 639-45.
143. Lane SJ, Wilkinson JRW, Cochrane GM, Lee TH, Arm JP. (1993) Differential in vitro regulation by glucocorticoids of monocyte-derived cytokine generation in glucocorticoid-resistant bronchial asthma. Am Rev Respir Dis 147: 690-6.
144. Vecciarelli A, Siracusa A, Cenki E, Pulti M, Abbriti G. (1992) Effect of corticoid treatment on interleukin-1 and tumor necrosis factor secretion by monocytes from subjects with asthma. Clin Exp Allergy 22: 365-70.
145. Corrigan CJ, Brown PH, Barnes NC, Tsai J, Frew AJ, Kay AB. (1991) Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis 144: 1026-32.
146. Brown PH, Teelucksingh S, Matusiewicz SP, Greening AP, Crompton GK, Edwards CRW. (1991) Cutaneous vasoconstrictor responses to glucocorticoids in asthma. Lancet 337: 576-80.
147. Sousa AR, Lane SJ, Atkinson BA, Poston RN, Lee TH. (1996) The effects of prednisolone on the cutaneous tuberculin response in patients with corticosteroid-resistant bronchial asthma. J Allergy Clin Immunol 97: 698-706.
148. Lane SJ, Lee TH. (1991) Glucocorticoid receptor characteristics in monocytes of patients with corticosteroid-resistant bronchial asthma. Am Rev Respir Dis 143: 1020-4.
149. Sher ER, Leung YM, Surs W, et al. (1994) Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 93: 33-9.
150. Kam JC, Szefler SJ, Surs W, Sher FR, Leung DYM. (1993) Combination IL-2 and IL-4 reduces glucocorticoid-receptor binding affinity and T cell response to glucocorticoids. J Immunol 151: 3460-6.
151. Spahn JD, Szefler SJ, Surs W, Doherty DE, Nimmagadda SR, Leung DY. (1996) A novel action of IL-13: induction of diminished monocyte glucocorticoid receptor-binding affinity. J Immunol 157: 2654-9.
152. Leung DYM, Hamid Q, Vottero A, et al. (1997) Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J Exp Med 186: 1567-74.
153. Hecht K, Carlstedt-Duke J, Stierna P, Gustaffson J, Bronnegard M, Wilkstrom A. (1997) Evidence that the β-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J Biol Chem 272: 26659-64.
154. Adcock IM, Lane SJ, Brown CA, Peters MJ, Lee TH, Barnes PJ. (1995) Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 154: 3000-5.
155. Adcock IM, Lane SJ, Brown CA, Lee TH, Barnes PJ. (1995) Abnormal glucocorticoid receptor/AP-1 interaction in steroid resistant asthma. J Exp Med 182: 1951-8.
156. Adcock IM, Lane SJ, Barnes PJ, Lee TH. (1996) Enhanced phorbol ester-induced c-Fos transcription and translation in steroid-resistant asthma. Am J Respir Crit Care Med 153: A682.
157. Adcock IM, Brady H, Lim S, Karin M, Barnes PJ. (1997) Increased JUN kinase activity in peripheral blood monocytes from steroid-resistant asthmatic subjects. Am J Respir Crit Care Med 155: A288.
158. Rosewicz S, McDonald AR, Maddux BA, Godfine ID, Miesfeld RL, Logsden CD. (1988) Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem 263: 2581-4.
159. Adcock IM, Brown CR, Shirasaki H, Barnes PJ. (1994) Effects of dexamethasone on cytokine and phorbol ester stimulated c-Fos and c-Jun DNA binding and gene expression in human lung. Eur Respir J 7: 2117-23.
160. Yang-Yen H, Chambard J, Sun Y, et al. (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205-15.
161. Vacca A, Screpanati I, Maroder M, Petrangeli E, Frati L, Guline A. (1989) Tumor promoting phorbol ester and raw oncogene expression inhibit the glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat. Mol Endocrinol 3: 1659-65.
162. Wong CS, Wamedna I, Pavord ID, Tattersfield AE. (1994) Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge. Am J Respir Crit Care Med 150: 1268-78.
163. 2-agonists in asthma. Trends Pharmacol Sci (1992) 13: 20-3.
164. Heck S, Kullmann M, Grast A, et al. (1994) A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 13: 4087-95.
165. Adcock IM, Barnes PJ. (1996) Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation. Am J Respir Crit Care Med 153: A243.
166. Vayssiere BM, Dupont S, Choquart A, et al. (1997) Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol Endocrinol II: 1245-55.
167. Barnes PJ, Adcock IM. (1997) NF-κB: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci 18:46-50.
168. Schreck R, Rieber P, Baeuerle PA. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10: 2247-58.
169. Miyajima T, Kotake Y. (1995) Spin trapping agent, phenyl N-tert-butyl nitrone, inhibits induction of nitric oxide synthase in endotoxin-induced shock in mice. Biochem Biophys Res Commun 215: 114-21.
170. Pahl HL, Krauss B, Schultze-Osthoff K, et al. (1996) The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB. J Exp Med 183: 1829-40.
171. van Deventer SJ, Elson CO, Fedorak RN. (1997) Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology 113: 383-9.
172. Yaron A, Gonen H, Alkalay I, et al. (1997) Inhibition of NF-κB cellular function via specific targeting of the IκB-ubiquitin ligase. EMBO J 16: 6486-94.
173. Wrighton CJ, Hofer-Warbinek R, Moll T, Eytner R, Bach FH, de Martin R. (1996) Inhibition of endothelial cell activation by adenovirus-mediated expression of IκBα, an inhibitor of transcription factor NF-κB. J Exp Med 183: 1013-22.
174. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. (1995) Embroyonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature (London) 376: 167-70.
175. Sha WC, Liou HC, Tuomanen EI, Baltimore D. (1995) Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80: 321-30.
176. Wright LC, Cammisuli S, Baboulene L, Fozzard J, Adcock IM, Barnes PJ. (1995) Cyclosporin A and glucocorticoids interact synergistically in T lymphocytes: implications for asthma therapy. Am J Respir Crit Care Med 151: A675.
177. Wallace J, Adcock IM, Barnes PJ. (1996) Retinoic acid potentiates the inhibitory effects of dexamethasone on AP-1 DNA binding in epithelial cells. Am J Respir Crit Care Med 153: A209.
178. Rowe A. (1997) Retinoid X receptors. Int J Biochem Cell Biol 29: 275-8.